Gene therapy of hematopoietic stem cells: Strategies for improvement

被引:8
作者
Hossle, JP [1 ]
Seger, RA [1 ]
Steinhoff, D [1 ]
机构
[1] Univ Zurich, Childrens Hosp, Div Immunol Hematol Oncol, CH-8032 Zurich, Switzerland
来源
NEWS IN PHYSIOLOGICAL SCIENCES | 2002年 / 17卷
关键词
D O I
10.1152/nips.01343.2001
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Gene therapy of hematopoietic stem cells (HSC) is limited by low frequency of the target cells, their quiescent nature, poor engraftment of treated HSC, and lack of a selective growth advantage of genetically modified cells. Lentiviral vectors combined with positive selection strategies using conditional cell-growth switches should allow for improvement.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 21 条
[1]   MYELOSUPPRESSIVE CONDITIONING IMPROVES AUTOLOGOUS ENGRAFTMENT OF GENETICALLY MARKED HEMATOPOIETIC REPOPULATING CELLS IN DOGS [J].
BARQUINERO, J ;
KIEM, HP ;
VONKALLE, C ;
DAROVSKY, B ;
GOEHLE, S ;
GRAHAM, T ;
SEIDEL, K ;
STORB, R ;
SCHUENING, FG .
BLOOD, 1995, 85 (05) :1195-1201
[2]   Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells [J].
Becker, S ;
Wasser, S ;
Hauses, M ;
Hossle, JP ;
Ott, MG ;
Dinauer, MC ;
Ganser, A ;
Hoelzer, D ;
Seger, R ;
Grez, M .
HUMAN GENE THERAPY, 1998, 9 (11) :1561-1570
[3]  
Brenner S, 2000, BLOOD, V96, p430A
[4]   Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice [J].
Bunting, KD ;
Galipeau, J ;
Topham, D ;
Benaim, E ;
Sorrentino, BP .
BLOOD, 1998, 92 (07) :2269-2279
[5]   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].
Cavazzana-Calvo, M ;
Hacein-Bey, S ;
Basile, CD ;
Gross, F ;
Yvon, E ;
Nusbaum, P ;
Selz, F ;
Hue, C ;
Certain, S ;
Casanova, JL ;
Bousso, P ;
Le Deist, F ;
Fischer, A .
SCIENCE, 2000, 288 (5466) :669-672
[6]  
Choi UM, 2000, BLOOD, V96, p805A
[7]   Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0 [J].
Glimm, H ;
Oh, IL ;
Eaves, CJ .
BLOOD, 2000, 96 (13) :4185-4193
[8]   Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture [J].
Glimm, H ;
Eaves, CJ .
BLOOD, 1999, 94 (07) :2161-2168
[9]   The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit [J].
Habibian, HK ;
Peters, SO ;
Hsieh, CC ;
Wuu, J ;
Vergilis, K ;
Grimaldi, CI ;
Reilly, J ;
Carlson, JE ;
Frimberger, AE ;
Stewart, FM ;
Quesenberry, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :393-398
[10]   Targeted expansion of genetically modified bone marrow cells [J].
Jin, LQ ;
Siritanaratkul, N ;
Emery, DW ;
Richard, RE ;
Kaushansky, K ;
Papayannopoulou, T ;
Blau, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8093-8097